The global erythropoietin drug market is witnessing substantial growth due to the increasing prevalence of chronic kidney disease, cancer-related anemia, and advancements in biologic therapeutics. Erythropoietin drugs are widely used to stimulate red blood cell production in patients suffering from anemia caused by chemotherapy, renal disorders, and other chronic illnesses. The growing elderly...